FishtownFish wrapped around the rod of AsclepiusMedicine
Philadelphia Primary Care
How It Works
What People Say
Patient reviews across 6 platforms
Articles
Symptoms
What your body is telling you
Treatments
Protocols, prescriptions, therapies
Longevity
Medicine 3.0 strategies
Heart Health & Risk
Protect your heart & vessels
Metabolism
Insulin, blood sugar, weight
Hormones
TRT, thyroid, menopause, andropause
Performance
VO2 max, muscle, sleep, gut
Playbooks
Step-by-step frameworks
About
Meet Dr. Ash
Your Physician
GERO·SPAN
Our Clinical Framework
FAQ
Common Questions
Book a Free Call
Why Your "Normal" LDL Can Hide Real Heart Risk
Fishtown Medicine•9 min read
4.96 (124)

Why Your "Normal" LDL Can Hide Real Heart Risk

Ashvin Vijayakumar MD

Medically Reviewed

Ashvin Vijayakumar MD•Updated May 23, 2026
On This Page
  • The Standard of Care Is Falling Short
  • Why Do People With "Normal" Cholesterol Still Have Heart Attacks?
  • The Highway Analogy
  • What Is Lipoprotein(a) and Why Does It Matter?
  • Can We Actually See Plaque Before a Heart Attack?
  • CT Angiogram (CCTA) vs. Calcium Score (CAC)
  • What Tools Do You Use to Lower Heart Risk?
  • What Is the Medicine 3.0 Strategy for Heart Disease?
  • A Word on Statins
  • Guidance from the Clinic
  • Actionable Steps in Philly
  • Supplements for Cardiovascular Support
  • Common Questions
  • Why do people with normal cholesterol still get heart attacks?
  • What is Lp(a) and why do I need to test for it?
  • What is the difference between a Calcium Score and a CT Angiogram?
  • What is a good ApoB level?
  • Is heart disease really preventable?
  • How often should I check my ApoB?
  • Does diet alone fix high ApoB?
  • Are statins safe for long-term use?
  • Can young adults have heart disease?
  • Do I still need testing if I exercise and eat well?
  • Deep Questions
  • How does ApoB actually cause plaque?
  • Why do some doctors still focus only on LDL-C?
  • What is "discordance" between LDL and ApoB?
  • How does insulin resistance change heart risk?
  • Can Lp(a) ever be lowered?
  • What is hsCRP and why do you check it?
  • Should I get a CT angiogram if I feel fine?
  • Are there risks to a CT angiogram?
  • What about advanced lipid tests like NMR?
  • How do PCSK9 inhibitors compare to statins?
  • Does sleep apnea raise heart risk?
  • How does alcohol affect heart disease risk?
  • Is there a role for a coronary calcium score at any point?
  • What do you do if soft plaque is found on imaging?
  • How does stress show up in your heart numbers?
  • Why do you focus on "lifetime risk" instead of 10-year risk?
  • Where does Philadelphia healthcare fit into all this?
  • How do I know if my plan is actually working?
  • Scientific References

Get a preventive doctor that knows you.

Consult Dr. Ash
TL;DR · 30-second take

A 'normal' LDL cholesterol can still hide serious heart risk because LDL only measures the weight of cholesterol, not the number of particles bumping into your artery walls. Better tests include ApoB (particle count), Lp(a) (a genetic risk marker), and a CT angiogram of the heart.

Why Your "Normal" LDL Can Hide Real Heart Risk

The Standard of Care Is Falling Short

Heart disease is still the number one killer because most clinics rely on outdated tests like LDL-C and only treat people after damage has already happened. In my practice, I use advanced blood markers (ApoB, Lp(a)) and detailed heart imaging to find and slow plaque buildup decades before a heart attack is on the table. Here is my honest, contrarian view. Heart disease should not be the leading cause of death. With the tools we have in 2026, it should sit much further down the list. The fact that it is still on top is a gap in how we use what we already know, not a gap in the science. Here is what really keeps me up at night. For more than half of men, and even more women, the very first sign of heart disease is not chest pain. It is sudden cardiac death. Research keeps confirming this. The first time a person learns they have a problem should not be the day it kills them. Every week in Philadelphia, I meet patients who left their previous doctor's office with a "normal" cholesterol report, then come to me years later asking why no one warned them. So I practice what I call Preventive Cardiology 3.0. I do not wait for an abnormal stress test. I work from a simple idea: atherosclerosis (plaque buildup inside the arteries) starts in childhood and shows up in adulthood. My goal is thorough, early prevention, so your risk of a heart attack stays as close to zero as biology allows.

Why Do People With "Normal" Cholesterol Still Have Heart Attacks?

LDL-C measures the weight of cholesterol in your blood, but ApoB counts the actual number of harmful particles. Particle number is what drives risk, so checking ApoB catches silent danger that a standard panel misses. The standard lipid panel (Total Cholesterol, LDL-C, HDL-C, Triglycerides) was designed decades ago. It is a blunt tool.
  • LDL-C (Low-Density Lipoprotein Cholesterol) measures the weight or concentration of cholesterol in your blood.
  • ApoB (Apolipoprotein B) counts the number of particles that can crash into your artery wall and start plaque.

The Highway Analogy

Picture your artery as a highway.
  • LDL-C tells you the total weight of the cargo inside the trucks.
  • ApoB tells you the number of trucks on the road.
A traffic jam (atherosclerosis) is caused by the number of trucks, not the weight of what they carry. You can have "normal" LDL-C but a dangerously high ApoB count, a mismatch we call discordance. That is exactly why people with "normal" cholesterol still have heart attacks. We measure ApoB in every patient.

What Is Lipoprotein(a) and Why Does It Matter?

Lipoprotein(a), or Lp(a), is an inflammatory, genetically set particle that affects about one in five adults. Diet and exercise barely move it, so every adult should be screened for Lp(a) once to understand their true heart risk. Roughly 20% of the population carries a genetic risk factor that most primary care doctors never test for. It is called Lipoprotein(a), often written as Lp(a) and read as "Lipoprotein(a)". Lp(a) is a sticky, inflammatory cousin of LDL. It is locked in by your DNA, so kale and marathons have almost no effect on it. If your Lp(a) is high, your risk of a heart attack jumps no matter how clean your lifestyle looks on paper. Every adult should have Lp(a) checked at least once. If it is high, we get even more thorough about every other risk factor we can move. If you do not know your number, you are flying blind.

Can We Actually See Plaque Before a Heart Attack?

Yes. Modern AI-supported CT angiograms (CCTA) show the real state of your arteries, both the hard and the soft plaque, so we move from guessing risk to seeing it. Standard medicine often waits for chest pain, then orders a stress test. A stress test only flags a blockage when an artery is more than 70% closed off. It says nothing about a 40% blockage that could rupture tomorrow. I believe in looking directly at the arteries, not guessing and not waiting.

CT Angiogram (CCTA) vs. Calcium Score (CAC)

  • CT Angiogram (CCTA): Uses a contrast dye to show all plaque, both calcified and soft, inside the artery walls. This is the gold standard for early detection. AI-powered analysis (such as Cleerly) measures plaque down to the millimeter.
  • Calcium Score (CAC): Only measures calcified (hard) plaque, which is the "history" of old damage. A score of 0 does not mean you are safe, because soft, vulnerable plaque, the kind that drives most heart attacks, will not show up at all. We treat this test as incomplete for true risk assessment.

Fishtown Medicine

A 90-minute conversation with Dr. Ash. A written plan you can actually follow.

Book a Free 20-Min Call

What Tools Do You Use to Lower Heart Risk?

Lowering cardiovascular risk takes a two-part plan: lifestyle and supplement strategies that calm inflammation, plus precise medications when lifestyle alone cannot drive ApoB low enough. We do not rely on watchful waiting. We use every safe tool we have to slow or stop plaque progression.
FocusFunctional Strategy (Optimization)Traditional Strategy (Disease Eradication)
Plaque StabilizationAged Garlic Extract: Studies suggest it helps stabilize soft plaque and slow progression.Statins (Rosuvastatin/Atorvastatin): A core tool for stabilizing plaque and lowering inflammation (hsCRP).
Lipid LoweringBerberine / Red Yeast Rice: Natural compounds that act on similar pathways to statins. They are weaker, but useful for patients who cannot tolerate statins.PCSK9 Inhibitors / Bempedoic Acid: Newer non-statin drugs that lower ApoB significantly without typical statin muscle aches.
Endothelial HealthMagnesium and Nitric Oxide support: Helps relax arteries and improve blood flow.ACE Inhibitors / ARBs: Keep blood pressure under 120/80 to prevent mechanical damage to artery walls.
Metabolic ControlFiber and Omega-3s: Bind bile acids and lower triglycerides.GLP-1 Agonists / SGLT2 Inhibitors: Lower insulin resistance and reduce cardiovascular death risk.
Risk Assessmenths-CRP / Homocysteine: Track ongoing inflammation.ApoB / Lp(a): Track the actual particles that drive disease.

What Is the Medicine 3.0 Strategy for Heart Disease?

The Medicine 3.0 approach treats heart disease based on lifetime risk, not a 10-year score. We use early, intentional lipid management, including non-statin options like PCSK9 inhibitors when needed, to keep arteries clean for decades. If we find risk, we act. We do not wait for a heart attack to be the trigger for treatment.

A Word on Statins

There is a lot of fear about statins online. Statins are not the only tool, but they are often the right tool for people with genetically high ApoB. In Medicine 3.0 we have more options now. We use PCSK9 inhibitors (injectables), Ezetimibe, and Bempedoic Acid to bring ApoB down to physiologic lows (for example, under 60 mg/dL, or under 30 mg/dL for very high risk patients) without the muscle aches some people get on statins.

Guidance from the Clinic

Dr. Ash
"Atherosclerosis is a pediatric disease with a geriatric presentation. By keeping your ApoB low and your blood vessels healthy for decades, we make it almost impossible for you to die from a heart attack."
Why I Push So Hard: I have read the post-mortem reports. The 45-year-old marathoner with a 70% LAD blockage no one caught because his LDL looked "normal." The executive who passed every stress test and then collapsed four months later. I have sat with families who asked, "How did we miss this?" That experience shapes my urgency. I look for it now so you never have to ask that question.
"Dr. Ash, my dad had a heart attack at 50. Am I doomed?" Here is how I think about it. Genetics deal the cards, but lifestyle plays the hand. In your case, we have a lot of room to play that hand differently. Heart disease is unique because it is slow. It takes decades to build a real blockage. That gives us a long runway. If we keep your ApoB low, your blood pressure optimized, and your insulin sensitivity high for 20 years, it becomes very hard, biologically, to grow enough plaque to kill you. I do not just "manage" heart disease. I aim to remove it from your future.

Actionable Steps in Philly

Do not wait for your primary care doctor to offer these tests. Ask for ApoB and Lp(a), and schedule a heart CT angiogram if you are over 40. Data is the antidote to anxiety.
  1. Get an ApoB Test: Do not settle for LDL alone. Ask for ApoB.
  2. Check Lp(a) Once: If you have a family history of heart disease, do this soon.
  3. Know Your Plaque: If you are a man over 40 or a woman over 50, a CT angiogram (CCTA) shows both calcified and soft plaque, catching what a calcium score alone would miss. Out-of-pocket cost is around $300 to $500, and insurance often covers it when there is a clinical reason.

Supplements for Cardiovascular Support

Beyond medications, these evidence-backed supplements can support heart health:
  • CoQ10: Helps mitochondria make energy, especially for people on a statin.
  • NAC (N-Acetyl Cysteine): Supports glutathione (an antioxidant your body makes) and lowers oxidative stress.
  • Omega-3 Fatty Acids: Lower triglycerides and reduce inflammation.
At Fishtown Medicine, we handle the prescriptions, the scheduling with local imaging centers (like Penn or Jefferson), and the careful read of every result.
Protect your engine. Book Your Warm Invitation Call Here

Scientific References

  1. Strong JP, et al. Prevalence and extent of atherosclerosis in adolescents and young adults. JAMA. 1999;281(8):727-735. The landmark PDAY study establishing that heart disease begins in childhood.
  2. Sniderman AD, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295. Demonstrates why ApoB is a superior predictor of risk compared to LDL-C.
  3. Tsimikas S. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. J Am Coll Cardiol. 2017;69(6):692-711. Highlights that ~20% of the population has elevated Lp(a).
  4. The SCOT-HEART Investigators. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med. 2018;379:924-933. Validates the use of CCTA for clarifying risk and reducing heart attacks.
  5. Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020;41(1):111-188. Establishes intensive ApoB targets (< 65 mg/dL) for high-risk prevention.
  6. Zheng ZJ, et al. Sudden Cardiac Death in the United States, 1989 to 1998. Circulation. 2001. Confirms that >50% of CHD deaths occur out of hospital/suddenly.
  7. Fox CS, et al. Parental Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-Aged Adults (The Framingham Heart Study). Circulation. 2004. Highlighting the often silent, sudden nature of first events.
Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right plan must be matched to your unique lab work, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, especially if you have chronic health conditions or are taking prescription medications.

Frequently Asked Questions

Common Questions

People with normal cholesterol still get heart attacks because the standard LDL-C test only measures the weight of cholesterol, not the number of harmful particles. You can have a "normal" LDL number but a high count of small, dense particles, measured by ApoB, that drive plaque buildup. Checking ApoB closes that blind spot.
Lp(a) is a genetic, sticky form of cholesterol that promotes both clotting and inflammation, and it affects about 20% of adults. Because Lp(a) is set by your DNA, you only need to test it once to know if you carry that elevated risk. Knowing your number changes how thoroughly we manage everything else.
A Calcium Score (CAC) only sees calcified, "hard" plaque, which is the scar of old damage. A CT Angiogram (CCTA) uses contrast dye to show all plaque, both hard and soft, so it picks up the dangerous, rupture-prone plaque a calcium score misses. We prefer CCTA for true risk assessment.
A "good" ApoB level depends on your overall risk. Standard labs call 90 to 100 mg/dL "normal," but for true heart protection we aim for under 60 mg/dL. If you already have plaque, we may target under 30 to 40 mg/dL to halt progression.
Heart disease is largely preventable for most people if we start early. Plaque takes decades to build, so consistent control of ApoB, blood pressure, and insulin sensitivity dramatically lowers lifetime risk. It is not a guarantee, but the odds shift heavily in your favor.
Most adults should check ApoB at least once a year, and more often if we are actively adjusting medications or lifestyle. Ranges can shift quickly with diet, weight, and treatment. Repeat testing helps us see whether a plan is actually working for you.
Diet alone can lower ApoB modestly, especially when saturated fat and refined carbs come down and fiber goes up. For some people, that is enough. For others, especially those with strong genetic drivers, lifestyle change must be paired with medication to reach the target.
Statins are well studied and, for most people, safe for long-term use. A small number of patients have real muscle or glucose side effects, and we take those seriously. When that happens, we switch to alternatives like ezetimibe, bempedoic acid, or a PCSK9 inhibitor.
Yes, young adults can have early heart disease, even in their 20s and 30s. Autopsy studies of young trauma victims often show fatty streaks and early plaque. Catching high ApoB or Lp(a) at 25 is far easier to manage than waiting until 55.
Yes, you still need testing even if you exercise and eat well, because lifestyle does not override every genetic factor. Lp(a), familial high ApoB, and early insulin resistance can all hide behind a fit appearance. One round of testing gives you peace of mind or a real plan.

Deep-Dive Questions

ApoB-containing particles squeeze into the artery wall, get trapped, and become oxidized. Immune cells then rush in to clean up, swell up with fat, and form the early "fatty streak" of atherosclerosis. The more ApoB particles you have circulating, the more often this process happens.
Many doctors still focus only on LDL-C because guidelines and insurance reimbursement updated slowly, and LDL-C is cheap and widely available. ApoB testing is now recommended by major societies, but old habits in primary care take time to change. That is why patients often have to ask for ApoB by name.
Discordance means your LDL-C and ApoB numbers tell different stories. Some people have a "normal" LDL-C but a high ApoB, which means many small, dense particles are quietly raising risk. In those cases, ApoB is the more honest signal of what is happening in the artery wall.
Insulin resistance pushes the liver to make more triglyceride-rich, ApoB-containing particles, which raises your particle count even when LDL-C looks fine. It also drives inflammation, blood pressure, and small dense LDL. That is why we treat metabolic health and heart health as the same project.
For now, no lifestyle change reliably lowers Lp(a) in a meaningful way. Niacin and PCSK9 inhibitors lower it modestly, and several targeted Lp(a) drugs are in late-stage trials. Until those are available, we lower every other risk factor as much as possible to compensate.
hsCRP, or high-sensitivity C-reactive protein, is a blood marker of low-grade inflammation. Elevated hsCRP suggests your blood vessels are in an inflamed state, which makes plaque more likely to grow and rupture. Tracking hsCRP alongside ApoB gives us a more complete picture of risk.
Feeling fine is exactly when a CT angiogram is most useful, because heart disease is silent until it is not. If you are over 40 with any risk factors, or have a strong family history, imaging gives you a direct look at your arteries instead of relying on a calculator. That data lets us right-size your prevention plan.
Yes, a CT angiogram involves a small dose of radiation and IV contrast dye, and there is a low risk of an allergic reaction or kidney stress. For most healthy adults, the information gained outweighs that small risk. We screen for kidney function and allergies before any imaging.
NMR-based tests give particle size and number, which can be helpful in nuanced cases. For most patients, ApoB tells us what we need at lower cost. We add NMR or similar testing when the picture is unusual, or when we are fine-tuning therapy in someone with complex metabolic disease.
PCSK9 inhibitors are injectable medications that lower ApoB even more than high-dose statins, with a different side effect profile. They tend to be very well tolerated and are useful for people with genetically high LDL or for those who cannot tolerate statins. Cost and prior authorization are the main hurdles.
Yes, untreated sleep apnea raises blood pressure, sympathetic nervous system tone, and inflammation, all of which feed heart disease. If you snore, wake up tired, or have a thick neck and high blood pressure, a sleep study is worth doing. Treating apnea often improves blood pressure and rhythm problems.
Alcohol has a complicated relationship with heart disease. Light intake was once thought to be protective, but newer data suggest the cleanest answer is that less is better, especially for blood pressure, atrial fibrillation, and triglycerides. We do not preach about it, we just show the patient what the data and their wearables say.
A coronary calcium score (CAC) is still useful as a quick, low-cost screen, especially for people who cannot get a CT angiogram. A score above 0 confirms the presence of plaque and changes the conversation about treatment. We just do not use a score of 0 as proof of safety.
If soft plaque shows up on imaging, we get serious about every lever. That usually means lowering ApoB aggressively (often well under 60 mg/dL), tightening blood pressure, treating insulin resistance, and rechecking imaging in 1 to 2 years to see if the plaque is stabilizing. Soft plaque can be made more stable with the right plan.
Stress shows up as higher resting heart rate, lower heart rate variability, higher blood pressure, and worse sleep, all of which raise long-term cardiovascular risk. Wearables make these patterns visible. We use that data to guide changes in workload, sleep, and recovery, not to add another thing to feel guilty about.
A 10-year risk score is too short a window for someone in their 30s or 40s, because plaque is built over decades. Lifetime risk gives a more honest picture of where you are headed if nothing changes. That is what justifies starting prevention early instead of waiting for a calculated risk to cross an arbitrary line.
Philadelphia has world-class imaging and cardiology at Penn, Jefferson, Temple, and Main Line Health. The gap is usually in coordination, who orders the right test, who reads it well, and who turns the result into a plan. That coordination is a big part of what we do at Fishtown Medicine.
You know your plan is working when ApoB drops to your target, blood pressure stays in range, hsCRP comes down, and follow-up imaging shows stable or shrinking soft plaque. We track these together, not in isolation. If a number is not moving, we change the plan rather than blaming the patient.

Still have a question?

He answers personally. Usually within a few hours.

Related Intelligence

Healthspan vs Lifespan: Why Living Longer Is Not Enough | Philadelphia

Healthspan vs Lifespan: Why Living Longer Is Not Enough | Philadelphia

Americans live to about 78 but spend the last 12 years sick and dependent. A Philadelphia primary care practice on why healthspan is the real metric.

Read Deep Dive
Accidental Death Prevention Philadelphia | The Missing Horseman of Medicine 3.0

Accidental Death Prevention Philadelphia | The Missing Horseman of Medicine 3.0

The number one cause of death for people under 45 is not cancer or heart disease. It is accidental injury. How to prevent the unforced error in your longevity plan.

Read Deep Dive
Emotional Health and Longevity Philadelphia | Medicine 3.0

Emotional Health and Longevity Philadelphia | Medicine 3.0

Suicide and overdose are leading causes of death for adults under 45. How a Philadelphia primary care practice integrates emotional health into longevity care.

Read Deep Dive

Talk it through with Dr. Ash.

If anything you read here raised a question, this is a free 20-minute Warm Invitation Call. Pick a time and we’ll work through it together.

HSA/FSA eligible
No initiation or cancellation fees
No copays

Loading scheduler...

Having trouble with the scheduler? Book directly on Dr. Ash’s calendar

FishtownFish wrapped around the rod of AsclepiusMedicine
Philadelphia Primary Care
2418 E York St, Philadelphia, PA 19125Home visits in Greater Philadelphia

Serving Fishtown · Art Museum · Bella Vista · Callowhill · Center City · Center City West · Chestnut Hill · East Kensington · Fairmount · Fitler Square · Graduate Hospital · Logan Square · Manayunk · Northern Liberties · Old City · Olde Richmond · Poplar · Port Richmond · Queen Village · Rittenhouse · Roxborough · Society Hill · Southwark

Explore by topic

Women’s Health
  • Perimenopause
  • Menopause 3.0
  • PCOS
  • Fertility
Men’s Health
  • TRT Therapy
  • TRT Safety
  • TRT vs Enclomiphene
  • Low Libido
Metabolic
  • Medical Weight Loss
  • Ozempic vs Metformin
  • Fasting Protocols
  • Visceral Fat
Cardiovascular
  • apoB & Heart Health
  • apoB vs LDL
  • Lp(a) Cholesterol
  • ED & Heart Risk
Longevity + Performance
  • Healthspan vs Lifespan
  • Biological Age
  • VO2 Max
  • Zone 2 Training
Supplements
  • Magnesium
  • Creatine
  • Omega-3
  • Foundational Stack

Content is for educational purposes only and does not constitute medical advice.

TermsPrivacyScope of PracticeClinical Independence